Renovaro Biosciences (NASDAQ:RENB) | Finanzwire

Basculer en Français

9472	Companies
185369	Keywords
117719	Articles
99261	Press releases

Home
Companies
Renovaro Biosciences

BRIEF

published on 09/09/2025 at 14:52, 2 months 25 days ago

Lunai Bioworks Inc. Launches Innovative AI Platform to Enhance Drug Discovery and Security

Therapeutic Development AI-powered Drug Discovery Generative AI Security Biological Risk Intelligence Biodefense Innovation
PRESS RELEASE

published on 09/09/2025 at 14:47, 2 months 25 days ago

Lunai Bioworks Inc. Unveils Transformer Platform to Secure Generative AI and Accelerate Drug Discovery
Lunai Bioworks launches platform embedding risk intelligence into AI pipelines for faster therapeutic development and biodefense. The solution safeguards against misuse of generative AI

Generative AI Biodefense AI-powered Drug Discovery Lunai Bioworks Risk Intelligence
BRIEF

published on 07/28/2025 at 16:43, 4 months 7 days ago

Renovaro Biosciences Bolsters AI Capabilities with New Patents

Drug Discovery Data Integration Patents Biomedical AI Federated Learning
PRESS RELEASE

published on 07/28/2025 at 16:38, 4 months 7 days ago

Renovaro Secures Key AI Patents, Strengthening Market Position in $20B Biomedical AI Sector
Renovaro announces significant strengthening of competitive position in biomedical artificial intelligence through multiple U.S. patent allowances, focusing on federated learning and precision medicine growth

Precision Medicine Federated Learning Renovaro Biomedical Artificial Intelligence Patent Allowances

Accesswire

Published on 12/05/2025 at 02:35, 3 hours 31 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 3 hours 36 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 5 hours 6 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 1 minute ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 6 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 03:30, 2 hours 35 minutes ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 15 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 40 minutes ago

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 51 minutes ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 55 minutes ago

SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance

Les Echos

Published on 12/04/2025 at 18:00, 12 hours 6 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 21 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 22 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 5 minutes ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago

Declaration of voting rights at the end of November 2025

View all LES ECHOS COMFI WIRE